Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Drotaverine Hydrochloride Injection

Approval Number

国药准字H20249323

Company陕西丽彩药业有限公司

Registration Date

November 15, 2024

Drug Information

Generic Name

盐酸屈他维林注射液

Dosage Form

注射剂

Strength

2ml:40mg(以C₂₄H₃₁NO₄·HCl计)

Drug Type

化学药品

Registration Date

November 15, 2024

Company Information

Applicant Company

Company Name陕西丽彩药业有限公司

Company Address

陕西省咸阳市秦都区人民西路29号丽彩金方圆广场B座29层

Manufacturing Company

Company Name山西诺成制药有限公司

Company Address

山西省怀仁市高新技术工业园区

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy